Blog

Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT Meeting – GlobeNewswire (press release)


Voice Of Analysts

Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT Meeting
GlobeNewswire (press release)
Each subject received a single intravenous injection of the gene therapy for systemic delivery of a functional copy of the missing SGSH gene associated with onset and progression of the disease. Select updated data from the presentation are highlighted …
Abeona Therapeutics (ABEO) Announces Clinical Update on MPS IIIA Gene Therapy TrialStreetInsider.com


Abeo down 12% on gene therapy data in SanfilippoSeeking Alpha

all 39 news articles »

2018-05-18 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.